» Articles » PMID: 34503413

The Role of Mitochondrial Genes in Neurodegenerative Disorders

Overview
Date 2021 Sep 10
PMID 34503413
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial disorders are clinically heterogeneous, resulting from nuclear gene and mitochondrial mutations that disturb the mitochondrial functions and dynamics. There is a lack of evidence linking mtDNA mutations to neurodegenerative disorders, mainly due to the absence of noticeable neuropathological lesions in postmortem samples. This review describes various gene mutations in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and stroke. These abnormalities, including PINK1, Parkin, and SOD1 mutations, seem to reveal mitochondrial dysfunctions due to either mtDNA mutation or deletion, the mechanism of which remains unclear in depth.

Citing Articles

Upgrading Mitochondria-Targeting Peptide-Based Nanocomplexes for Zebrafish In Vivo Compatibility Assays.

Faria R, Vives E, Boisguerin P, Descamps S, Sousa A, Costa D Pharmaceutics. 2024; 16(7).

PMID: 39065658 PMC: 11281276. DOI: 10.3390/pharmaceutics16070961.


Neuroglobin overexpression in cerebellar neurons of Harlequin mice improves mitochondrial homeostasis and reduces ataxic behavior.

Cwerman-Thibault H, Malko-Baverel V, Le Guilloux G, Ratcliffe E, Mouri D, Torres-Cuevas I Mol Ther. 2024; 32(7):2150-2175.

PMID: 38796706 PMC: 11286817. DOI: 10.1016/j.ymthe.2024.05.030.


The role of mitochondrial dynamics in disease.

Wang Y, Dai X, Li H, Jiang H, Zhou J, Zhang S MedComm (2020). 2023; 4(6):e462.

PMID: 38156294 PMC: 10753647. DOI: 10.1002/mco2.462.


A primordial target: Mitochondria mediate both primary and collateral anesthetic effects of volatile anesthetics.

Perouansky M, Johnson-Schlitz D, Sedensky M, Morgan P Exp Biol Med (Maywood). 2023; 248(7):545-552.

PMID: 37208922 PMC: 10350799. DOI: 10.1177/15353702231165025.


Microneedles: A Versatile Drug Delivery Carrier for Phytobioactive Compounds as a Therapeutic Modulator for Targeting Mitochondrial Dysfunction in the Management of Neurodegenerative Diseases.

Bandiwadekar A, Khot K, Gopan G, Jose J Curr Neuropharmacol. 2022; 22(6):1110-1128.

PMID: 36237157 PMC: 10964109. DOI: 10.2174/1570159X20666221012142247.


References
1.
Szczesny B, Tann A, Longley M, Copeland W, Mitra S . Long patch base excision repair in mammalian mitochondrial genomes. J Biol Chem. 2008; 283(39):26349-56. PMC: 2546560. DOI: 10.1074/jbc.M803491200. View

2.
Zoccolella S, Artuso L, Capozzo R, Amati A, Guerra F, Simone I . Mitochondrial genome large rearrangements in the skeletal muscle of a patient with PMA. Eur J Neurol. 2012; 19(7):e63-4. DOI: 10.1111/j.1468-1331.2012.03720.x. View

3.
Alexiou A, Soursou G, Chatzichronis S, Gasparatos E, Kamal M, Yarla N . Role of GTPases in the Regulation of Mitochondrial Dynamics in Alzheimer's Disease and CNS-Related Disorders. Mol Neurobiol. 2018; 56(6):4530-4538. DOI: 10.1007/s12035-018-1397-x. View

4.
Bogenhagen D . Mitochondrial DNA nucleoid structure. Biochim Biophys Acta. 2011; 1819(9-10):914-20. DOI: 10.1016/j.bbagrm.2011.11.005. View

5.
Bradley-Whitman M, Lovell M . Epigenetic changes in the progression of Alzheimer's disease. Mech Ageing Dev. 2013; 134(10):486-95. PMC: 3857018. DOI: 10.1016/j.mad.2013.08.005. View